PofoliaShared via Pofolia

Homeopathy· 2026Q2

Individualized Homeopathic Medicines in Treating Depression, Anxiety, and Stress in Adults with Osteoarthritis of the Knee: A Double-Blind, Randomized, Placebo-Controlled Trial

Meghamala Chakraborty, Rajat Chatterjee, Madhushree Mondal, Sayantan Bhowmick et al.

Short summary

Individualized homeopathic medicines (IHMs) significantly improved depression, anxiety, and stress symptoms in adults with knee osteoarthritis (OA) compared to placebo over 3 months (p < 0.001), with higher responder rates (59% vs. 11%).

AI-generated from the title and abstract; the full text is not read.

Key points

  • IHMs significantly reduced depression, anxiety, and stress in knee OA patients compared to placebo (p < 0.001).
  • Clinically meaningful improvements were observed in knee function and pain (KOOS, WOMAC) with IHMs.
  • Responder rates were substantially higher for IHMs (59%) versus placebo (11%).
  • Pain reduction partially mediated improvements in depression.
  • No adverse events were reported during the 3-month trial.

AI-generated from the title and abstract; the full text is not read.

Abstract

Abstract Knee osteoarthritis (OA) is frequently accompanied by depression, anxiety and stress, worsening pain, disability and quality of life. Evidence for individualized homeopathic medicines (IHMs) in addressing these co-existing psychological and physical burdens remains limited. This trial aimed to evaluate the efficacy and safety of IHMs compared with placebo in adults with knee OA and co-morbid depression, anxiety and/or stress. A double-blind, randomized (2:1), placebo-controlled, clinical trial was conducted at a teaching hospital in Kolkata, India. One hundred and ten participants aged between 50 and 70 years with knee OA (American College of Rheumatology [ACR] criteria) and mild-to-moderate depression (DASS-21) were randomized to receive IHMs plus concomitant care (CC) or placebo plus concomitant care for 3 months. Remedies were individualized through standardized homeopathic case-taking. Outcomes (DASS-21, Knee Injury and Osteoarthritis Outcome Score [KOOS], WOMAC, and Measure Yourself Medical Outcome Profile version 2 [MYMOP-2]) were assessed monthly for 3 months. Efficacy was assessed using multivariate linear mixed-effects models (primary test: Intervention × time interaction). Area under the curve analyses, effect sizes, and sensitivity analyses using Generalized Estimating Equations, and responder analyses were performed. Adjusted p-values used the Holm–Bonferroni method. A significant group-by-time interaction favored IHMs for DASS-21 depression (p < 0.001), anxiety, and stress, alongside clinically meaningful improvements in KOOS and the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain, function, and quality of life (most adjusted p < 0.001). Responder rates were higher with IHMs (59% vs. 11%). Mediation analysis indicated that pain reduction partially explained improvements in depression. No adverse events were reported. IHMs produced significant improvements in both psychological symptoms and physical outcomes related to knee OA compared with placebo, reflecting a holistic therapeutic effect without adverse events. CTRI/2024/03/064632.

The authors' abstract, as published at the source. Homeopathy, 2026 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Complementary and alternative medicine

Complementary and alternative medicineMedicine